: A Phase 3, Single-Arm, Multi-Dose, Pharmacokinetic Comparability Trial between TAK-881 and HYQVIA in Adults with Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Clinical Trial Grant
Administered By
Neurology, Neuromuscular Disease
Awarded By
Takeda Development Center Americas, Inc
Start Date
May 13, 2025
End Date
January 1, 2028
Administered By
Neurology, Neuromuscular Disease
Awarded By
Takeda Development Center Americas, Inc
Start Date
May 13, 2025
End Date
January 1, 2028